Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, November 4, 2022
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
Matthew Harrison Maintained (AMGN) at Buy with Increased Target to $282 on, Nov 4th, 2022
Matthew Harrison of Morgan Stanley, Maintained "Amgen Inc." (AMGN) at Buy with Increased Target from $279 to $282 on, Nov 4th, 2022.
Matthew has made no other calls on AMGN in the last 4 months.
There are 3 other peers that have a rating on AMGN. Out of the 3 peers that are also analyzing AMGN, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Kennen MacKay of "RBC Capital" Maintained at Hold with Increased Target to $236 on, Friday, August 5th, 2022
These are the ratings of the 2 analyists that currently disagree with Matthew
- Carter Gould of "Barclays" Downgraded from Hold to Sell and Held Target at $234 on, Monday, October 31st, 2022
- Steve Chesney of "Atlantic Equities" Maintained at Sell with Decreased Target to $182 on, Tuesday, August 9th, 2022
